Dubai's DFSA sanctions upheld against Dr Mubashir Sheikh for serious misconduct

The FMT imposed the action on Dr Sheikh because it found that he demonstrated a lack of integrity by knowingly acting dishonestly and deceptively

  
A general view of The Gate building at Dubai International Financial Centre (DIFC) in Dubai, United Arab Emirates June 20, 2019. Picture taken June 20, 2019.

A general view of The Gate building at Dubai International Financial Centre (DIFC) in Dubai, United Arab Emirates June 20, 2019. Picture taken June 20, 2019.

REUTERS/Christopher Pike

UAE - The Financial Markets Tribunal (FMT) has upheld enforcement action taken by the Dubai Financial Services Authority (DFSA) against Dr Mubashir Ahmed Sheikh for serious misconduct including misleading and deceptive behaviour.

Following a five-day hearing in April of this year, the FMT issued its decision on October 20, upholding the DFSA’s findings and imposing the following sanctions: a fine of $225,000; a direction that Dr Sheikh pay restitution of at least $644,836 to MAS Clearsight (MAS) representing the cash he had previously withdrawn in a deceptive way, along with interest; a prohibition from holding office in or being an employee of certain DFSA-regulated entities; and a restriction from performing any function in connection with the provision of Financial Services in or from the DIFC.

Dr Sheikh was the chairman, senior executive officer and majority beneficial owner of MAS, formerly a DFSA Authorised Firm which has been in liquidation since November 2015. As publicised in the DFSA’s media release, dated October 3, 2019, the DFSA decided to take action against Dr Sheikh for breaches of DFSA legislation. Dr Sheikh disputed the DFSA’s findings and referred the action to the FMT for review. The FMT is a specialist tribunal, operationally independent of the DFSA, which has its own rules of procedure. The FMT conducts a full merits review of DFSA decisions that are referred to it and determines the appropriate action for the DFSA to take.

The restitution direction is the first ever imposed on an individual, and the fine is the highest imposed on an individual. In addition, the FMT ordered Dr Sheikh to pay $15,000 towards the DFSA’s costs.

The FMT imposed the action on Dr Sheikh because it found that he demonstrated a lack of integrity by knowingly acting dishonestly and deceptively; knowingly provided false, misleading or deceptive information to the DFSA; and knowingly caused MAS to breach the DFSA’s prudential rules.

In its decision, the FMT described Dr Sheikh’s misconduct as a “dishonest set of steps aggravated by devious acts to try to conceal and cover up over a long period”. The FMT also found that Dr Sheikh knew full well that his withdrawals had been causing MAS to breach its regulatory capital requirement “because his story of the deal is a lie”.

Bryan Stirewalt, chief executive of the DFSA, said: “The DFSA has zero tolerance for individuals who deliberately mislead and attempt to deceive the regulator, particularly where an individual takes such elaborate and dishonest steps to conceal their conduct. Such individuals will be held accountable to the fullest degree of the law, and they have no place in the DIFC. The DFSA will also require, where appropriate, wrongdoers to compensate those who have suffered losses arising from their misconduct. Individuals in control of financial services firms must manage the firm’s finances responsibly, in the interest of all stakeholders including employees, and act with integrity at all times.”

The FMT refused Dr Sheikh permission to appeal its decision to the DIFC Court. Dr Sheikh did not file an application to the DIFC Courts for permission to appeal against the FMT’s decision and, therefore, the FMT’s decision is final. The FMT’s decision can be found on the FMT section of the DFSA website, and a copy of it can be accessed via this link. Information about pending FMT matters, including details of any public hearings, can be found via the same link.

 
 

Copyright © 2020 Khaleej Times. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Commercial